|
S. no. | Pharmacological activity | Extract, fraction, and isolate | Parts used | Dose/mode of administration | Standard | Study model/parameter | Result | Ref. |
|
1 | Antiallergic activity | Ethanolic extract | Stem bark | 50 to 300 mg/kg, p.o. | DSCG (50 mg/kg, i.p.) | Mast cell stabilization, compound 48/80-induced systemic anaphylaxis | Dose-dependent mast cell stabilization activity at 200 and 300 mg/kg dose extract protected the degranulation (53 and 61%, resp.). There was significant protection from degranulation (compound 48/80 induced) of mast cells, dose-dependent, that is, 61 and 74% of inhibition of histamine release at 200 and 300 mg/kg, respectively | [15] |
Chloroform, methanol, and water extracts | Leaf and stem bark | 50 μg/ml | 1% DMSO | In vitro mesenteric mast cell stabilization against compound 48/80 | All the extracts showed significant mast cell stabilization activity. However, methanolic and water extracts of the bark showed the maximum activity along with the leaf methanolic extract | [51] |
|
2 | Anti-Alzheimer’s activity | Hydromethanolic extract | Seed | 100–300 mg/kg p.o. | Galantamine 0.5 mg/kg | In vivo aluminum chloride (100 mg/kg, p.o.)-induced Alzheimer’s disease in Wistar albino rats | Extracts significantly improved the memory and cognitive impairments, ↑GSH, SOD, CAT, and ↓ AChE | [21] |
Morris water maze, open field, hole board, Y-maze, and T-maze test |
3 | Anticancer activity | Saponin-rich fraction | Bark | 0.001, 0.01, 0.1, 1, and 10 μg/ml | Doxorubicin 500 nM | In vitro MTT assay in human breast cancer MCF-7 | Fraction inhibits the growth of MCF-7 with IC50 1 μg/ml | [9] |
10 μg/ml | Staurosporine 1 ug/ml | Apoptosis assay | Fraction increases apoptosis and promotes activation of caspases 3 and 8 |
0.1, 0.5, and 1 μg/ml | | Shell-less chick embryo culture assay | Reduction in number of extremities, nodes, junctions, and total branches length between 0 and 3 hr and 0 and6 hr of drug exposure |
| | Chromosomal aberration (CA) assay | ↑ Total chromosomal aberrations |
Zinc oxide nanoparticles | Stem bark | 5, 25, 50, and 100 μg/ml of 0.1 M, 0.05 M, and 0.01 M ZnO NPs | | In vitro MTT assay in human breast cancer MCF-7 and MDA-MB 231 | Extract significantly inhibited the viability | [57] |
Lebbeckosides A-B | Root | | Tamoxifen | In vitro cytotoxicity against the glioblastoma stem-like TG1 cells and human glioblastoma U-87 MG cell lines | Lebbeckoside A and B showed cytotoxicity against TG1 and U-87 MG, with IC50 2.10, 2.24, 3.46, and 1.36 μM, respectively | [31] |
Crude methanol extract | Leaves | 1, 10, 25, 50, 75, 100, 125, and 150 μg/ml | | In vitro MTT assay against human hepatocarcinoma (HepG2) cancer cell line | Extract significantly decreased the cell viability with IC50 24.03 μg/ml | [52] |
|
4 | Antidiabetic activity | Methanolic extract | Bark | 200, 350, and 620 mg/kg/day, p.o. | Metformin 45 mg/kg | Streptozotocin-nicotinamide-induced type II diabetes mellitus using female Sprague-Dawley rats | Extract significantly decreased the level of serum GLU, creatinine, urea, triglycerides, cholesterol, low-density lipoprotein-cholesterol, and very low-density lipoprotein-cholesterol and increased high-density lipoprotein levels | [16] |
Geraldone, isookanin, and luteolin | Bark | | Acarbose 10 mg/ml | In vitro α-glucosidase and α-amylase inhibitory assay | All three compounds significantly inhibit the α-glucosidase and α-amylase enzymes | [17] |
Methanol/dichloromethane extract | Stem bark | 100–400 mg/kg | Glibenclamide 1 mg/kg | In vivo streptozotocin-induced diabetic rats using male albino Wistar rats | Significant reduction of blood glucose, BUN, SCr, GSP, TC, TG, LDL-c, and VLDL-c and increasing plasma insulin level, hepatic enzymes, SOD, CAT, GSH, and HDL-c | [18] |
|
5 | Antidiarrheal activity | Aqueous methanol extract | Seed | 2.5–5 mg/kg i.p. | Loperamide 1 mg/kg i.p. | In vivo castor oil-induced diarrhea using albino rats and mice | Extract significantly inhibited the cathartic effect of castor oil in a dose-dependent manner | [63] |
6 | Anti-inflammatory activity | Essential oil | Leaves | 100–400 mg/kg p.o. | Ibuprofen 100 mg/kg | In vivo carrageenan-induced edema in Wistar rats | Extract significantly and dose-dependently inhibited edema | [63] |
Aqueous and ethanolic extract | Leaves | 50–200 mg/kg, p.o. | Diclofenac 20 mg/kg and indomethacin 10 mg/kg | In vivo carrageenan-induced paw edema and cotton pellet-induced granuloma models using Wistar rats | Dose-dependent and significant inhibition of inflammation | [49] |
Petroleum ether, chloroform, and ethanol extract | Bark | 100, 200, and 400 mg/kg p.o. | Indomethacin 10 mg/kg | In vivo carrageenan- and dextran-induced rat paw edema; cotton pellet-induced granuloma; adjuvant-induced arthritis using female Wistar rats | Dose-dependent and significant inhibition of inflammation | [28] |
n-Hexane, dichloromethane, ethyl acetate, and n-butanol fraction | Flower | 0.25 and 1 g/kg, i.p. | Diclofenac sodium 20 mg/kg | In vivo carrageenan-induced paw edema using Wistar rats | All fractions showed significant inhibition | [37] |
Petroleum ether: ethyl acetate: methanol extract (1 : 1:1) | Bark | 200 and 400 mg/kg p.o. | Phenylbutazone 100 mg/kg | In vivo carrageenan-induced rat hind paw edema using long-Evans rats | Dose-dependent and significant inhibition of inflammation | [56] |
|
7 | Antimicrobial activity | Zinc oxide nanoparticles | Stem bark | 0.01 M, 0.05 M, and 0.1 M | Ciprofloxacin 10 μg/disc | In vitro agar disc diffusion method using Bacillus cereus, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Salmonella typhi | Extract showed strong activity with inhibition zone ranging from 1 to 10.57 mm | [57] |
Ethanolic extract | Root | 100–200 mg/ml | Ciprofloxacin | In vitro disc diffusion method using Escherichia coli, Shigella flexneri, Pseudomonas aeruginosa, Staphylococcus aureus, and four clinical bacterial isolates Salmonella typhi, Klebsiella pneumoniae, Shigella boydii, and Enterococcus faecalis | Extract showed activity against all tested bacteria with a zone of inhibition ranging from 9.05 to 15.77 mm and MIC 0.20–1.56 mg/ml | [30] |
Petroleum ether, ethyl acetate, and methanol extracts | Stem bark | 300 μg/disc | Ciprofloxacin 10 μg/disc for bacteria; griseofulvin 25 μg/disc for fungi | In vitro disc diffusion method using Bacillus polymyxa, B. subtilis, B. megaterium, Sarcina lutea, Staphylococcus aureus, Vibrio mimicus, V. Cholera, Salmonella typhi, Shigella boydii, S. flexneri type-1, S. dysenteriae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Candida arrizae, Aspergillus fumigatus, A. niger, Rhizopus oryzae, Candida albicans, C. krusei, and Saccharomyces cerevisiae | Pet. ether and ethyl acetate extract showed activity against selective microbes with ZOI ranging from 6 to 14 mm. Methanol extract is only active against S. cerevisiae (8 mm) | [58] |
Petroleum ether, ethyl acetate, and methanol extract | Leaves | 50, 100, 200, and 500 μg/ml | Tetracycline, streptomycin, erythromycin, lincomycin, rifampicin, norfloxacin, and gentamycin | In vitro agar disc diffusion method using Bacillus subtilis, Escherichia coli, Klebsiella pneumonia, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella typhi, and Staphylococcus aureus | Among extracts, methanolic extract showed strong activity with a zone of inhibition ranging from 11 to 23 mm at 500 μg/ml | [19] |
Crude methanol extract | Leaves | 10 mg/ml | Ampicillin 10 mg/ml, streptomycin 10 mg/ml, and tetracycline 20 mg/ml | In vitro agar well diffusion method against Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, and Escherichia coli | Extract showed potent antibacterial activity against S. aureus and E. coli with ZOI 6 and 7.5 mm, respectively | [52] |
8 | Antinociceptive activity | Essential oil | Leaves | 100–400 mg/kg p.o. | Piroxicam 10 mg/kg p.o. | In vivo formalin hind paw in Wistar rats | Extract inhibited nociceptive mediators at both neurogenic and inflammatory phases | [11] |
Aqueous and ethanolic extract | Leaves | 50–200 mg/kg, p.o. | Pentazocine 15 mg/kg | In vivo Eddy’s hot plate and tail-flick test in Wistar rats | Both extracts showed a significant and dose-dependent increase in the mean basal reaction time in the hot plate test and latency of the flick tail response | [26] |
n-Hexane, dichloromethane, ethyl acetate, and n-butanol fraction | Flower | 0.25 and 1 g/kg, i.p. | Aspirin 200 mg/kg | In vivo hot plate method using male albino white mice | Only dichloromethane fraction (1 g/kg) significantly increases in pain threshold | [37] |
Petroleum ether: ethyl acetate: methanol extract (1 : 1:1) | Bark | 200 and 400 mg/kg p.o. | Aminopyrine 50 mg/kg | Acetic acid induced writhing test using Swiss albino mice | Extract showed a significant and dose-dependent reduction in the number of writhes | [56] |
Morphine 2 mg/kg | Radiant heat tail-flick method using Swiss albino mice | Extract showed significant elongation of tail flicking time |
|
9 | Antioxidant activity | Zinc oxide nanoparticles | Stem bark | 0.01, 0.05, and 0.1 M | Ascorbic acid | H2O2-free radical scavenging assay | IC50 48.7, 60.2, and 48.5 μg/ml, respectively | [57] |
Geraldone, isookanin, and luteolin | Bark | | Trolox | DPPH radical scavenging assay | All compounds showed activity with IC50 21.5, 31.8, and 29.26 μM, respectively | [17] |
Petroleum ether, ethyl acetate, and methanol extracts | Stem bark | 20–100 μg/ml | Ascorbic acid | DPPH- and H2O2-free radical scavenging assay | Extracts showed DPPH- and H2O2-free radical scavenging activity with IC50 values of 66.63, 57.25, 60.21, 70.93, 64.69, and 68.99 μg/ml, respectively | [58] |
Crude methanol extract | Leaves | 1, 10, 25, 50, 75, 100, 125, and 150 μg/ml | Ascorbic acid | DPPH and ABTS radical scavenging assays | Extract exhibited DPPH and ABTS radical scavenging activity with IC50 34.22 and 108.7 μg/ml, respectively | [52] |
|
10 | Antiparasitic activity | Ethanolic extract | Bark | 5–100 μg/ml | Chloroquine 5 mg/kg | In vitro antimalarial activity against Plasmodium falciparum chloroquine (CQ) sensitive (MRC2) and CQ resistant (RKL9) strains | IC50 = 8.2 and 5.1 μg/ml against MRC2 and RKL9 strains | [14] |
Ethanolic extract | Bark | 100, 250, 500, 750, and 1000 mg/kg/day | Chloroquine 5 mg/kg and pyrimethamine 1.25 mg/kg | In vivo schizonticidal activity, repository, and curative activities using P. berghei-infected white Swiss albino mice | Dose-dependent chemosuppression was observed with significant schizonticidal activity at 1000 mg/kg with ED > 100 mg/kg. Significant curative and repository activities were exhibited by 750 mg/kg concentration of extract on day 7 | |
Methanol extract | Pericarp | 20 mg/ml | Chloroquine, miltefosine, benznidazole, and suramin | In vitro antiplasmodial, antileishmanial, and antitrypanosomal activities against Plasmodium falciparum, Leishmania infantum, Trypanosoma cruzi, and T. brucei | Extract showed antiparasitic activity with IC50 8.7, 8.1, 37.9, and 50.8 μg/ml against T. cruzi, T. brucei, P. falciparum, and L. infantum, respectively | [60] |
|
11 | Anti-Parkinson’s activity | Aqueous methanolic extract | Seed | 100–300 mg/kg | Sinemet-levodopa 100 mg + carbidopa 25 mg/kg per oral | In vivo haloperidol-induced catalepsy | Extract improved the motor functions and showed significant improvement in catalepsy, time latency, no. of exploration, ↑ SOD, CAT, and GSH | [12] |
Assessment of catalepsy, hang test, and narrow beam walk test |
Open field test |
12 | Antipyretic activity | n-Hexane, dichloromethane, ethyl acetate, and n-butanol fraction | Flower | 0.25 and 1 g/kg, i.p. | Aspirin (200 mg/kg) | In vivo Brewer’s yeast-induced pyrexia using albino mice | All fractions showed a decrease in temperature | [37] |
13 | Antivenom activity | Methanolic extract | Seed | 1: 1–1: 100 w/w | | Echis carinatus venom- (ECV-) induced local toxicity in Swiss albino mice in vivo and proteolytic and hyaluronidase activities in vitro | Extract inhibited protease and hyaluronidase (IC50 36.32 and 91.95 μg), hemorrhage (ED50 26.37 μg), serum creatinine kinase, and lactate dehydrogenase (ED50 37.5 and 31.44 μg) | [10] |
14 | Estrogenic activity | n-Hexane, dichloromethane, ethyl acetate, and n-butanol fraction | Flower | 200 and 500 mg/kg i.p. | 17-β-Estradiol (0.32 μg/animal/day) | Uterine weight using female Albino mice | Ethyl acetate (200) and total alcohol fraction (500 mg/kg) significantly decrease and increase uterine weight by 25.2 and 109%, respectively | [37] |
15 | Wound healing activity | Ethanolic extract | Root | 250, 500, and 750 mg/kg p.o. | Vitamin E 200 mg/kg | In vivo incision and excision wound models in nulliparous and nonpregnant healthy female rats | ↑ Wound breaking strength in incision model, complete wound contraction was observed on the 22nd day in excision model, ↑ wet weight of granulation tissue, total protein, SOD, GSH, hydroxyproline, hexosamine, hexuronic acid levels, ↓ lipid peroxidation, and nitric oxide | [30] |
|